Simulations Plus declares another quarterly dividend of $0.06 per share

Trending News ☀️

Simulations Plus ($NASDAQ:SLP), Inc. is a provider of simulation and modeling software for the pharmaceutical, biotechnology, and chemical industries. The company has announced a quarterly dividend of $0.06 per share, payable on November 7 to shareholders of record on October 31. This dividend is in line with previous payments, and the ex-dividend date is October 28. Simulations Plus has a long history of paying dividends to shareholders, and this latest payment underscores the company’s commitment to returning value to investors. The company’s software products are used by customers around the world to help them design and optimize new drugs and chemicals. The company’s dividend payout ratio is modest, at just under 30%, which leaves room for future dividend increases.

Simulations Plus has a strong balance sheet, with plenty of cash on hand to cover its dividend payments. The company is profitable and generates healthy cash flow. Simulations Plus is a good option for income-seeking investors looking for a reliable dividend stock. The company has a strong business model, solid financials, and a long history of paying dividends. The stock is worth considering for a diversified portfolio.

Dividends

Simulations Plus, Inc. , a leading provider of simulation and modeling software for the pharmaceutical, biotechnology, and chemicals industries, today announced that its Board of Directors has declared a quarterly dividend of $0.06 per share. This marks the company’s fourth consecutive quarterly dividend, and brings the total dividends paid out in the last twelve months to $0.24 per share. Looking ahead, Simulations Plus is committed to continuing to grow its dividend program, with the goal of providing shareholders with a consistent and growing stream of income. This provides the company with the flexibility to invest in new products and technologies, as well as to return cash to shareholders through dividends and share repurchases.

Market Price

On Thursday, Simulations Plus stock opened at $46.2 and closed at $43.9, down by 5.0% from previous closing price of 46.2. The company has declared another quarterly dividend of $0.06 per share. Simulations Plus is a leading provider of simulation and modeling software for the pharmaceutical, biotechnology, and chemicals industries. The company’s software is used by scientists and engineers to predict the behavior of complex systems and to design and optimize new products and processes.

VI Analysis

The company’s products are used in the design and analysis of clinical trials, chemical process development, and regulatory submissions. Simulations Plus has a strong competitive advantage in the market due to its unique product offerings and efficient operations. The company’s products are used by leading pharmaceutical and biotechnology companies worldwide, which gives it a stable and high revenue growth.

Additionally, Simulations Plus is highly profitable, with an operating margin of over 30%. Simulations Plus is a strong candidate for investment by growth-oriented investors. The company’s products are in high demand by the pharmaceutical and biotechnology industries, and its efficient operations provide a high level of profitability. Additionally, Simulations Plus pays a dividend, which provides income for investors.

VI Peers

The company was founded in 1986 and is headquartered in Lancaster, California. Simulations Plus Inc has three main competitors: Schrodinger Inc, Intercare DX Inc, and KDA Group Inc.

– Schrodinger Inc ($NASDAQ:SDGR)

Schrodinger Inc is a publicly traded company with a market capitalization of 1.52 billion as of 2022. The company has a return on equity of -15.16%. Schrodinger is a technology and software company that focuses on improving scientific discoveries through advanced computing. The company was founded in 1990 and is headquartered in New York City.

– Intercare DX Inc ($OTCPK:ICCO)

KDA Group Inc is a provider of engineering, construction and project management services. The company has a market cap of 14.81M as of 2022 and a Return on Equity of -120.56%. KDA Group Inc provides services to a range of industries including healthcare, education, commercial and institutional. The company has a strong focus on quality and safety and is committed to providing a high level of customer service.

Summary

Simulations Plus is a company that provides software for pharmaceutical and biotechnology companies, as well as for academic institutions. The company’s products are used to simulate the effects of drugs and other substances on the human body. Simulations Plus has a strong track record of dividend growth, and its shares have outperformed the market over the past five years. The company is well-positioned to continue its growth, and its shares are a good option for investors looking for income and capital appreciation.